Skip Nav Destination
FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult
Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma
Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)
Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model
Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation
Issue Archive
Table of Contents
INSIDE BLOOD COMMENTARIES
BLOOD FORUM
REVIEW ARTICLE
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
Clinical Trials & Observations
R.-O. Casasnovas,L. Ysebaert,C. Thieblemont,E. Bachy,P. Feugier,A. Delmer,S. Tricot,J. Gabarre,M. Andre,C. Fruchart,N. Mounier,R. Delarue,M. Meignan,A. Berriolo-Riedinger,S. Bardet,J.-F. Emile,J.-P. Jais,C. Haioun,H. Tilly,F. Morschhauser
GENE THERAPY
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult
Clinical Trials & Observations
Emma C. Morris,Thomas Fox,Ronjon Chakraverty,Rita Tendeiro,Katie Snell,Christine Rivat,Sarah Grace,Kimberly Gilmour,Sarita Workman,Karen Buckland,Katie Butler,Ronnie Chee,Alan D. Salama,Hazem Ibrahim,Havinder Hara,Cecile Duret,Fulvio Mavilio,Frances Male,Frederick D. Bushman,Anne Galy,Siobhan O. Burns,H. Bobby Gaspar,Adrian J. Thrasher
MYELOID NEOPLASIA
RED CELLS, IRON, AND ERYTHROPOIESIS
AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency
Charles Kung,Jeff Hixon,Penelope A. Kosinski,Giovanni Cianchetta,Gavin Histen,Yue Chen,Collin Hill,Stefan Gross,Yaguang Si,Kendall Johnson,Byron DeLaBarre,Zhiyong Luo,Zhiwei Gu,Gui Yao,Huachun Tang,Cheng Fang,Yingxia Xu,Xiaobing Lv,Scott Biller,Shin-San Michael Su,Hua Yang,Janeta Popovici-Muller,Francesco Salituro,Lee Silverman,Lenny Dang
Strict tropism for CD71+/CD234+ human reticulocytes limits the zoonotic potential of Plasmodium cynomolgi
Varakorn Kosaisavee,Rossarin Suwanarusk,Adeline C. Y. Chua,Dennis E. Kyle,Benoit Malleret,Rou Zhang,Mallika Imwong,Rawiwan Imerbsin,Ratawan Ubalee,Hugo Sámano-Sánchez,Bryan K. S. Yeung,Jessica J. Y. Ong,Eric Lombardini,François Nosten,Kevin S. W. Tan,Pablo Bifani,Georges Snounou,Laurent Rénia,Bruce Russell
THROMBOSIS AND HEMOSTASIS
LETTERS TO BLOOD
Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma
Clinical Trials & Observations
Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)
Clinical Trials & Observations
Fleur Cohen Aubart,Jean-François Emile,Fabrice Carrat,Frédéric Charlotte,Neila Benameur,Jean Donadieu,Philippe Maksud,Ahmed Idbaih,Stéphane Barete,Khê Hoang-Xuan,Zahir Amoura,Julien Haroche
Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model
Clinical Trials & Observations
Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation
Clinical Trials & Observations
BLOOD WORK
-
Cover Image
Cover Image
![issue cover]()
A human reticulocyte infected with Plasmodium cynomolgi, a malaria parasite of nonhuman primates (fixed thin-film preparation stained with Giemsa stain). The asexual P cynomolgi parasite shown is at the midtrophozoite stage (∼30 hours after red cell invasion) and is morphologically similar to its sister species, P vivax. While P cynomolgi infections do not show a specific red cell tropism in their normal hosts (Old World monkeys), human infections are restricted to CD71+/CD234+ reticulocytes. See the article by Kosaisavee et al on page 1357.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
